These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts. Wimperis JZ, Baglin TP, Marcus RE, Warren RE. Bone Marrow Transplant; 1991 Nov; 8(5):363-7. PubMed ID: 1768971 [Abstract] [Full Text] [Related]
3. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH. Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954 [Abstract] [Full Text] [Related]
5. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team. Alangaden G, Chandrasekar PH, Bailey E, Khaliq Y. Bone Marrow Transplant; 1994 Dec; 14(6):919-24. PubMed ID: 7711669 [Abstract] [Full Text] [Related]
7. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S. Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206 [Abstract] [Full Text] [Related]
11. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial. Timmers GJ, Zweegman S, Simoons-Smit AM, van Loenen AC, Touw D, Huijgens PC. Bone Marrow Transplant; 2000 Apr; 25(8):879-84. PubMed ID: 10808210 [Abstract] [Full Text] [Related]
14. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E, Montanari M, Centurioni R, Leoni P. Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158 [Abstract] [Full Text] [Related]
15. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W. Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812 [Abstract] [Full Text] [Related]